Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 20212249

Phase III placebo-controlled trial of denileukin diftitox for patients with cutaneous T-cell lymphoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2010 Apr 10
First author
Prince HM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Prince HM
      type
      Author
    2. name
      Duvic M
      type
      Author
    3. name
      Martin A
      type
      Author
    4. name
      Sterry W
      type
      Author
    5. name
      Assaf C
      type
      Author
    6. name
      Sun Y
      type
      Author
    7. name
      Straus D
      type
      Author
    8. name
      Acosta M
      type
      Author
    9. name
      Negro-Vilar A
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Prince HM
      type
      Author
    2. name
      Duvic M
      type
      Author
    3. name
      Martin A
      type
      Author
    4. name
      Sterry W
      type
      Author
    5. name
      Assaf C
      type
      Author
    6. name
      Sun Y
      type
      Author
    7. name
      Straus D
      type
      Author
    8. name
      Acosta M
      type
      Author
    9. name
      Negro-Vilar A
      type
      Author
    bibliography ids
    1. nci-bib-07baf68d8a5a0bb035ee2993
    book metadata
    content sha256
    60f4f4dadbb054ef7ddd07f52513a435030c78b93d178ff7439888e5f159dacb
    document type
    citation
    dois
    1. 10.1200/JCO.2009.26.2386
    electronic publication date
    display
    2010 Mar 8
    precision
    day
    year
    2010
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:20212249
    immutable id
    pubmed:20212249@60f4f4dadbb054ef7ddd07f52513a435030c78b93d178ff7439888e5f159dacb
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    11
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    1870-7
    volume
    28
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      20212249
      provenance
      batch id
      708c7929ee1eff455330
      provider
      NCBI PubMed ESummary
      record sha256
      46752b1f9fca01ed52231873f6ed2ff6c0b0a4191f5eb61eae18669fa8c9e179
      response sha256
      d245af3dbc636ffc79325b3798c7bfda16faf0a3d796681b12b8d89bd68eb450
      retrieved at
      2026-09-09T23:46:31.496840+00:00
      publication date
      display
      2010 Apr 10
      precision
      day
      year
      2010
      publication types
      1. Clinical Trial, Phase III
      2. Journal Article
      3. Multicenter Study
      4. Randomized Controlled Trial
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/20212249/
      title
      Phase III placebo-controlled trial of denileukin diftitox for patients with cutaneous T-cell lymphoma.

      Preserved source evidence · Not medical advice